European Medicines Agency Urges EU Member States To Postpone National Rollouts Of Russian Sputnik V Vaccine 08/03/2021 Madeleine Hoecklin A senior official at the European Medicines Agency (EMA) has cautioned EU member states to wait until the agency has reviewed the safety and efficacy data of Russia’s Sputnik V vaccine before granting the vaccine emergency use authorization at national level, and beginning mass rollouts. Last week, the EMA formally began a rolling review of […] Continue reading -> European Union Moves Forward With Plans For Vaccine Passport By Summer; Experts Concerned About Practicality, Safety & Equity 28/02/2021 Madeleine Hoecklin Leaders of the 27 European Union member states are moving closer to a consensus on an EU-wide system of vaccine certificates for travel between countries in the bloc. Within three months a system will be introduced, EU officials announced on Thursday, the first day of the two-day virtual summit of the European Council. Several EU […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Israel Produces Best Evidence Yet About Pfizer Vaccine – But Netanyahu’s Vaccine Politics & Airport Chaos Cast Shadow Over Success 25/02/2021 Elaine Ruth Fletcher The largest peer reviewed study to date of some 1.193 million Israelis – half of whom received the Pfizer COVID-19 vaccine – confirms the vaccine’s efficacy in preventing symptomatic COVID-19 as well as serious cases and deaths – even after the first dose is administered. The study, published in the New England Journal of Medicine, […] Continue reading -> The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> WHO Experts Recommend AstraZeneca COVID Vaccine Across All Ages & Countries – Signal For Start Of Global COVAX Vaccine Rollout 10/02/2021 Elaine Ruth Fletcher A World Health Organization expert group has recommended the use of the AstraZeneca two-dose COVID-19 vaccine for use in countries worldwide – and among groups including people over the age of 65. The sweeping recommendation by WHO “Strategic Advisory Group of Experts” (SAGE) marks what WHO Chief Scientist Soumya Swaminathan described as an “important milestone” […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Union Moves Forward With Plans For Vaccine Passport By Summer; Experts Concerned About Practicality, Safety & Equity 28/02/2021 Madeleine Hoecklin Leaders of the 27 European Union member states are moving closer to a consensus on an EU-wide system of vaccine certificates for travel between countries in the bloc. Within three months a system will be introduced, EU officials announced on Thursday, the first day of the two-day virtual summit of the European Council. Several EU […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Israel Produces Best Evidence Yet About Pfizer Vaccine – But Netanyahu’s Vaccine Politics & Airport Chaos Cast Shadow Over Success 25/02/2021 Elaine Ruth Fletcher The largest peer reviewed study to date of some 1.193 million Israelis – half of whom received the Pfizer COVID-19 vaccine – confirms the vaccine’s efficacy in preventing symptomatic COVID-19 as well as serious cases and deaths – even after the first dose is administered. The study, published in the New England Journal of Medicine, […] Continue reading -> The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> WHO Experts Recommend AstraZeneca COVID Vaccine Across All Ages & Countries – Signal For Start Of Global COVAX Vaccine Rollout 10/02/2021 Elaine Ruth Fletcher A World Health Organization expert group has recommended the use of the AstraZeneca two-dose COVID-19 vaccine for use in countries worldwide – and among groups including people over the age of 65. The sweeping recommendation by WHO “Strategic Advisory Group of Experts” (SAGE) marks what WHO Chief Scientist Soumya Swaminathan described as an “important milestone” […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Israel Produces Best Evidence Yet About Pfizer Vaccine – But Netanyahu’s Vaccine Politics & Airport Chaos Cast Shadow Over Success 25/02/2021 Elaine Ruth Fletcher The largest peer reviewed study to date of some 1.193 million Israelis – half of whom received the Pfizer COVID-19 vaccine – confirms the vaccine’s efficacy in preventing symptomatic COVID-19 as well as serious cases and deaths – even after the first dose is administered. The study, published in the New England Journal of Medicine, […] Continue reading -> The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> WHO Experts Recommend AstraZeneca COVID Vaccine Across All Ages & Countries – Signal For Start Of Global COVAX Vaccine Rollout 10/02/2021 Elaine Ruth Fletcher A World Health Organization expert group has recommended the use of the AstraZeneca two-dose COVID-19 vaccine for use in countries worldwide – and among groups including people over the age of 65. The sweeping recommendation by WHO “Strategic Advisory Group of Experts” (SAGE) marks what WHO Chief Scientist Soumya Swaminathan described as an “important milestone” […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Israel Produces Best Evidence Yet About Pfizer Vaccine – But Netanyahu’s Vaccine Politics & Airport Chaos Cast Shadow Over Success 25/02/2021 Elaine Ruth Fletcher The largest peer reviewed study to date of some 1.193 million Israelis – half of whom received the Pfizer COVID-19 vaccine – confirms the vaccine’s efficacy in preventing symptomatic COVID-19 as well as serious cases and deaths – even after the first dose is administered. The study, published in the New England Journal of Medicine, […] Continue reading -> The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> WHO Experts Recommend AstraZeneca COVID Vaccine Across All Ages & Countries – Signal For Start Of Global COVAX Vaccine Rollout 10/02/2021 Elaine Ruth Fletcher A World Health Organization expert group has recommended the use of the AstraZeneca two-dose COVID-19 vaccine for use in countries worldwide – and among groups including people over the age of 65. The sweeping recommendation by WHO “Strategic Advisory Group of Experts” (SAGE) marks what WHO Chief Scientist Soumya Swaminathan described as an “important milestone” […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> WHO Experts Recommend AstraZeneca COVID Vaccine Across All Ages & Countries – Signal For Start Of Global COVAX Vaccine Rollout 10/02/2021 Elaine Ruth Fletcher A World Health Organization expert group has recommended the use of the AstraZeneca two-dose COVID-19 vaccine for use in countries worldwide – and among groups including people over the age of 65. The sweeping recommendation by WHO “Strategic Advisory Group of Experts” (SAGE) marks what WHO Chief Scientist Soumya Swaminathan described as an “important milestone” […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> WHO Experts Recommend AstraZeneca COVID Vaccine Across All Ages & Countries – Signal For Start Of Global COVAX Vaccine Rollout 10/02/2021 Elaine Ruth Fletcher A World Health Organization expert group has recommended the use of the AstraZeneca two-dose COVID-19 vaccine for use in countries worldwide – and among groups including people over the age of 65. The sweeping recommendation by WHO “Strategic Advisory Group of Experts” (SAGE) marks what WHO Chief Scientist Soumya Swaminathan described as an “important milestone” […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Experts Recommend AstraZeneca COVID Vaccine Across All Ages & Countries – Signal For Start Of Global COVAX Vaccine Rollout 10/02/2021 Elaine Ruth Fletcher A World Health Organization expert group has recommended the use of the AstraZeneca two-dose COVID-19 vaccine for use in countries worldwide – and among groups including people over the age of 65. The sweeping recommendation by WHO “Strategic Advisory Group of Experts” (SAGE) marks what WHO Chief Scientist Soumya Swaminathan described as an “important milestone” […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts